Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03448289 · ClinicalTrials.gov registry record · NA
Use of a Reproductive Life Planning Tool at the Pediatric Well-Baby Visit With Postpartum Women
A NA study of Contraception Behavior and Primary Health Care, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 1
- Study location
NCT03448289: Completed NA study of Contraception Behavior and Primary Health Care, sponsored by University of Illinois at Chicago.
NCT03448289 is a NA study of Contraception Behavior and Primary Health Care that has completed, run by University of Illinois at Chicago. The registered enrollment target is 129 participants, below the 854-participant average among 11 other Contraception Behavior trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03448289, a NA study of Contraception Behavior and Primary Health Care, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
Improved access to timely health care and contraception in the postpartum (PP) period is needed to reduce unintended pregnancies and help women achieve desired birth spacing. While the routine 6-week visit has historically been considered the place for women to discuss and receive contraception, many women, particularly low-income women, do not attend the postpartum visit. A novel approach to increasing receipt of PP care and contraception is the adoption of a reproductive life planning tool. Explorations of the use of a self-administered Reproductive Life Plan Tool (RLPT) by pediatricians in the context of the Well-Baby Visit (WBV) with postpartum mothers, holds great promise. The objective of this study is to determine whether use of a simple self-administered Reproductive Life Plan Tool at the 2-month WBV increases the proportion of postpartum women receiving woman's health care and contraception at 6-months PP, compared to women not exposed to such an intervention. The two specific aims of the project are: 1) To determine if introducing a self-administered Reproductive Life Planning Tool (RLPT) with postpartum mothers during the 2-month WBV will increase the proportion of women receiving a well-woman primary care health visit by 6 months postpartum; and if introducing a self-administered Reproductive Life Planning Tool (RLPT) will increase utilization rates of contraception by 6 months postpartum. 2) To assess patient-, provider-, and systems-level barriers and facilitators to integrating a self-administered Reproductive Life Planning Tool (RLPT) designed to facilitate referral of postpartum women for primary well-woman care in the context of a pediatric clinic. The investigators hypothesize that exposure to a self-administered RLPT combined with a conversation with a pediatrician during a 2-month WBV will increase use of well-woman primary health care during the postpartum period as well as receipt of contraception, by 6-months postpartum. If successful, the
Primary Outcome
Change in receipt of primary care services will be ascertained by self-report on the 2-month and 6-month Postpartum interview.
Conditions Studied
Interventions
- BEHAVIORAL RLPT
Study Locations (1)
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2018-01-24 |
| Est. Completion | 2019-09-29 |
| Phase | NA |
What the finished NCT03448289 record still lists
NCT03448289 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 854-participant average among 11 other Contraception Behavior trials with a reported enrollment target (85% lower).
The record links to 4 conditions, with Contraception Behavior appearing as the primary indexed condition, and to 1 intervention - of which RLPT is the first listed.
NCT03448289 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03448289 about?
NCT03448289 is a clinical study titled "Use of a Reproductive Life Planning Tool at the Pediatric Well-Baby Visit With Postpartum Women". Improved access to timely health care and contraception in the postpartum (PP) period is needed to reduce unintended pregnancies and help women achieve desired birth spacing. While the routine 6-week visit has historically been considered the place for women to discuss and receive contraception, man...
What is the current status of trial NCT03448289?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2018-01-24. Estimated completion is 2019-09-29.
What conditions does trial NCT03448289 study?
This clinical trial studies the following conditions: Contraception Behavior, Primary Health Care, Women's Health, Postpartum Period.
What interventions are being tested in trial NCT03448289?
The interventions under investigation include: RLPT (BEHAVIORAL).
Who is sponsoring clinical trial NCT03448289?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03448289 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03448289's enrollment target sits among peer trials
129 10th of 11 higher than 2 of 11 other Contraception Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Patient-centered Information on Permanent Contraception
RECRUITING · NA
-
Effectiveness Testing of a Videogame Intervention (No Baby No) to Decrease Contraception Non-use Among Adolescents.
RECRUITING · NA
-
Evaluation of an Adolescent Pregnancy Prevention Program; Relationship Smarts+ With Lessons From Mind Matters
ACTIVE NOT RECRUITING · NA
-
Patient-Centered Reproductive Decision Support Tool for Women Veterans
COMPLETED · NA
-
Factors Predicting Ineffective Contraception Use
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI